Malignancies of the colorectum and anus in solid organ recipients

Transplant International

Volumn 20, Issue 6, 2007, Pages 497-504

  Aigner, Felix ^a   Boeckle, Ellen ^a   Albright, Jeffrey ^b   Kilo, Juliane ^a   Boesmueller, Claudia ^a   Conrad, Friedrich ^a   Wiesmayr, Silke ^a   Antretter, Herwig ^a   Margreiter, Raimund ^a   Mark, Walter ^a   Bonatti, Hugo ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MAYO CLINIC   (United States)

Author keywords

Colorectum; Immunosuppression; Malignancy; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CIDOFOVIR; CYCLOSPORIN A; FLUOROURACIL; MITOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER;

ADULT; AGED; ANUS NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTS;

EID: 34247847993     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00469.x     Document Type: Article

References (24)

1. Adami J, Gaebel H, Lindeloef B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. BJC 2003 89: 1221.
2. Sheil AGR. Cancer in dialysis and transplant patients. In: Morris PJ, ed. Kidney Transplantation. Principles and Practice, 5th edn. Philadelphia, PA: WB Saunders Company, 2001: 562 563.
3. Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol 2004 15: 1582.
4. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993 7: 431.
5. Parikshak M, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum 2002 45: 1655.
6. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyps Study Workgroup. N Engl J Med 1993 328: 901.
7. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000 61: 289.
8. Frisch M, Glimelius B, van den Brule AJC, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997 337: 1350.
9. Wienert V. Diagnostik und Therapie der analen intraepithelialen Neoplasie (AIN, Präkanzerose). Coloproctology 2005 27: 353.
10. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000 342: 792.
11. Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg 1987 11: 446.
12. Hoefer D, Bonatti H, Poelzl G, Mark W, Ott H, Antretter H. Cecal perforation as a rare initial manifestation of post-transplant lymphoproliferative disorder after cardiac transplantation. J Heart Lung Transplant 2005 24: 505.
13. Ries LAG, Eisner MP, Kosary CL, et al. (eds) SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute, Based on November 2004 SEER data submission.
14. Kahan BD, Yakupoglu YK, Schoenberg L, et al. Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 2005 80: 749.
15. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Muhlbacher F, Salat A. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004 17: 366.
16. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis 2005 16: 1.
17. Hayanaga A. Need for guidelines for screening in anal cancer: a lesson from cervical cancer. Letter. Dis Colon Rectum 2006 49: 1.
18. Scholefield JH, Castle MT, Watson NFS. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005 92: 1133.
19. Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001 88: 1330.
20. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 68: 1851.
21. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 1990 14 (Suppl. 1 92.
22. Younes BS, Ament ME, McDiarmid SV, Martin MG, Vargas JH. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1999 28: 375.
23. Ghobrial IM, Habermann TM, Maurer J, et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol 2005 23: 7574.
24. Allen UD, Farkas G, Hebert D, et al. Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 2005 9: 450.